论文部分内容阅读
目的探讨急性ST段抬高型心肌梗死(STEMI)患者首诊不能进行急诊经皮冠状动脉介入治疗(PCI),经保守治疗后,在急性期内长途转院上级医院行PCI治疗的安全性。方法 32例患者首诊选择不能进行急诊PCI手术治疗的医院,经保守治疗后,长途转运到上级医院,观察路途中出现急性事件及处理情况,并发症和死亡率。结果 32例患者均于6~15小时到达到达上级医院,有16人出现胸闷不适,经舌下含服药物缓解,8例出现了心律失常,经对症处理后缓解,无一例死亡。结论急性ST段抬高型心肌梗死(STEMI)患者首诊不能进行急诊经皮冠状动脉介入治疗(PCI),经保守治疗后,在急性期内长途转院上级医院行PCI治疗安全可行。
Objective To investigate the safety of PCI in patients with acute ST-elevation myocardial infarction (STEMI) who can not undergo emergency percutaneous coronary intervention (PCI) after initial diagnosis and after conservative treatment in the acute phase of long-distance transfer hospital. Methods Thirty-two patients were selected as the first hospital to be treated by emergency PCI. After conservative treatment, they were transported to the higher level hospital for long-distance transfusion. The incidence of acute events and treatment, complication and mortality were observed. Results 32 patients reached the superior hospital within 6 to 15 hours, 16 patients had chest tightness, relieved sublingual medication, 8 had arrhythmia, and were relieved after symptomatic treatment without any death. Conclusions The patients with acute STEMI can not be treated with emergency percutaneous coronary intervention (PCI) after the first diagnosis. After conservative treatment, the PCI of the long-distance transfer hospital in the acute phase is safe and feasible.